The treatment depicted significant telomere extension from 2.4 kb to 4 kb with doses of 0.5 and 1 g /ml in 21NT
doi: 10.2337/db13-1169 96 IwayaCNomiyamaTKomatsuSKawanamiTTsutsumiYHamaguchiYet al
Part D plans must use negotiated prices, while most-favored-nation pricing remains optional, creating potential confusion when the programs overlap
We talk about the side-effect profile honestly - the first eight weeks are typically the hardest, the GI side effects are real, and titration matters
Weinstein MM, Kang T, Lachman RS, Bamshad M, Nickerson DA, Krakow D, Cohn DH, "Somatic mosaicism for a lethal TRPV4 mutation results in non-lethal metatropic dysplasia", American journal of medical genetics